14.31 0 (0%) | 11-18 16:00 | |||||||||||||
|
|
Short term | ![]() |
|||
Mid term | ![]() |
|||
Targets | 6-month : | 16.71 | 1-year : | 19.52 |
Resists | First : | 14.31 | Second : | 16.71 |
Pivot price | 14.28 ![]() |
|||
Supports | First : | 14.25 ![]() |
Second : | 14.22 ![]() |
MAs | MA(5) : | 14.3 ![]() |
MA(20) : | 14.27 ![]() |
MA(100) : | 13.84 ![]() |
MA(250) : | 12.61 ![]() |
|
MACD | MACD : | 0 ![]() |
Signal : | 0 ![]() |
%K %D | K(14,3) : | 100 ![]() |
D(3) : | 95.2 ![]() |
RSI | RSI(14): 74.5 | |||
52-week | High : | 15.11 | Low : | 8.86 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ RCM ] has closed below upper band by 16.5%. Bollinger Bands are 91.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 64 bars. This is a sign that the market may be about to initiate a new trend.
If tomorrow: | Open lower | Open higher |
High: | 14.32 - 14.39 | 14.39 - 14.45 |
Low: | 14.13 - 14.21 | 14.21 - 14.29 |
Close: | 14.18 - 14.3 | 14.3 - 14.42 |
R1 RCM Inc. provides technology-driven solutions that transform the patient experience and financial performance of hospitals, health systems, and medical groups. It offers end-to-end revenue cycle management (RCM) services, which address the spectrum of revenue cycle challenges faced by healthcare providers. The company also provides modular services, including physician advisory services, which assists healthcare organizations in complying with payer requirements regarding whether to classify a hospital visit as an in-patient or an out-patient observation case for billing purposes; practice management services that offers administrative and operational support for patient care and outsource non-core functions; revenue integrity solutions, including charge capture, charge description master maintenance, and pricing services; coding management services, such as business intelligence and analysis, human capital management, accountability framework, and quality management programs; patient experience; and business office services. In addition, the company offers software-as-a-service based scheduling and patient access solutions. The company was founded in 2003 and is headquartered in Murray, Utah.
Tue, 14 Oct 2025
R1 to Acquire Phare Health, a Leading AI Platform for - GlobeNewswire
Thu, 25 Sep 2025
$8.9B Deal For Health Tech R1 RCM Draws Del. Chancery Suit - Law360
Fri, 12 Sep 2025
R1 RCM & Dignity Health to Pay $675,000 to Settle Data Breach Lawsuit - The HIPAA Journal
Thu, 17 Jul 2025
TowerBrook Capital Partners and Clayton, Dubilier & Rice take R1 RCM private in an $8.9 billion deal - RBC Capital Markets
Tue, 20 May 2025
How a New PE-Backed RCM Company Plans to Fix the ‘Transactional Bowels of US Healthcare’ - MedCity News
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
Exchange:
NASDAQ
|
|
Sector:
Healthcare
|
|
Industry:
Medical - Healthcare Information Services
|
|
Shares Out | 422 (M) |
Shares Float | 294 (M) |
Held by Insiders | 1 (%) |
Held by Institutions | 86.9 (%) |
Shares Short | 10,810 (K) |
Shares Short P.Month | 12,130 (K) |
EPS | -0.15 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 6.65 |
Profit Margin | -2.5 % |
Operating Margin | 3.7 % |
Return on Assets (ttm) | 2.3 % |
Return on Equity (ttm) | -2.3 % |
Qtrly Rev. Growth | 14.6 % |
Gross Profit (p.s.) | 0 |
Sales Per Share | 5.82 |
EBITDA (p.s.) | 1.22 |
Qtrly Earnings Growth | 0 % |
Operating Cash Flow | 291 (M) |
Levered Free Cash Flow | 269 (M) |
PE Ratio | -102.22 |
PEG Ratio | 0 |
Price to Book value | 2.14 |
Price to Sales | 2.45 |
Price to Cash Flow | 20.74 |
Dividend | 0 |
Forward Dividend | 0 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |